1 Result: Nasdaq:CLBS
Caladrius Announces Publication of Two-Year Results from Phase 1 Trial of Type 1 Diabetes Product Candidate in Science Translational Medicine
December 01st, 2015
Study demonstrated persistence of Tregs, safety and feasibility; supports upcoming Phase 2 study to test efficacy of the therapy Basking Ridge, NJ / CRWEPRESSRELEASE / December 1, 2015 – Caladrius Biosciences, Inc. (“Caladrius&rdq. Read more
Want To Find Some News?
News By Industries
August 30th, 2016August 29th, 2016August 29th, 2016